Total Payments
$1.7M
2024 Payments
$192,491
Companies
89
Transactions
3,985
Medicare Patients
983
Medicare Billing
$544,550
Payment Breakdown by Category
Other$1.2M (74.7%)
Consulting$250,896 (15.2%)
Travel$91,658 (5.5%)
Food & Beverage$70,689 (4.3%)
Research$5,158 (0.3%)
Gifts$300.00 (0.0%)
Education$262.72 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.2M | 484 | 69.9% |
| Consulting Fee | $250,896 | 127 | 15.2% |
| Travel and Lodging | $91,658 | 526 | 5.5% |
| Honoraria | $79,213 | 33 | 4.8% |
| Food and Beverage | $70,689 | 2,795 | 4.3% |
| Unspecified | $5,158 | 9 | 0.3% |
| Gift | $300.00 | 1 | 0.0% |
| Education | $262.72 | 9 | 0.0% |
| Grant | $41.50 | 1 | 0.0% |
Payments by Type
General
$1.6M
3,976 transactions
Research
$5,158
3 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $476,683 | 572 | $0 (2024) |
| Allergan, Inc. | $295,584 | 371 | $0 (2022) |
| Amgen Inc. | $284,336 | 444 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $111,417 | 258 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $110,471 | 222 | $0 (2021) |
| Lundbeck LLC | $102,503 | 234 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $56,748 | 144 | $0 (2022) |
| IMPEL PHARMACEUTICALS INC. | $43,708 | 91 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $37,873 | 73 | $0 (2022) |
| Promius Pharma LLC | $25,164 | 80 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $192,491 | 421 | ABBVIE INC. ($145,279) |
| 2023 | $182,427 | 381 | AbbVie Inc. ($127,471) |
| 2022 | $234,543 | 525 | ABBVIE INC. ($92,702) |
| 2021 | $324,947 | 608 | AbbVie Inc. ($111,230) |
| 2020 | $265,580 | 534 | Allergan, Inc. ($158,861) |
| 2019 | $171,899 | 547 | Amgen Inc. ($74,956) |
| 2018 | $178,457 | 550 | Amgen Inc. ($82,219) |
| 2017 | $103,459 | 419 | Depomed, Inc. ($23,030) |
All Payment Transactions
3,985 individual payment records from CMS Open Payments — Page 1 of 160
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Neurology | ||||||
| 12/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: PAIN | ||||||
| 12/20/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $16.70 | General |
| Category: Endocrinology | ||||||
| 12/19/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Pain Management | ||||||
| 12/19/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: Pain Management | ||||||
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $592.50 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/18/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: NEUROLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $3,160.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/17/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Immunology and Neurology | ||||||
| 12/17/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.78 | General |
| Category: NEUROLOGY | ||||||
| 12/14/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Pain Management | ||||||
| 12/11/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $41.43 | General |
| Category: Neurology | ||||||
| 12/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $129.02 | General |
| Category: Rare Disease | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $342.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $342.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: AMANTADINE | ||||||
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: AMANTADINE | ||||||
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: AMANTADINE | ||||||
| 11/26/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Neurology | ||||||
| 11/25/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $41.43 | General |
| Category: Central Nervous System | ||||||
| 11/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Neurology | ||||||
| 11/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: NEUROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 4 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF GALCANEZUMAB VERSUS RIMEGEPANT IN ADULT PARTICIPANTS WITH EPISODIC MIGRAINE | Eli Lilly and Company | $4,921 | 2 |
| A PHASE 4, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF GALCANEZUMAB VERSUS RIMEGEPANT IN ADULT PARTICIPANTS WITH EPISODIC MIGRAINE | Eli Lilly and Company | $237.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 215 | 11,117 | $163,393 | $69,105 |
| 2022 | 12 | 248 | 12,540 | $296,696 | $150,070 |
| 2021 | 12 | 297 | 18,043 | $322,794 | $166,172 |
| 2020 | 8 | 223 | 18,644 | $323,864 | $159,203 |
Total Patients
983
Total Services
60,344
Medicare Billing
$544,550
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 24 | 10,800 | $103,680 | $50,219 | 48.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 24 | 54 | $17,550 | $6,047 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $6,975 | $3,481 | 49.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 22 | 34 | $7,480 | $3,386 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 23 | $2,300 | $1,392 | 60.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 16 | 30 | $3,750 | $1,388 | 37.0% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 13 | 29 | $9,180 | $1,293 | 14.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $1,980 | $947.76 | 47.9% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 13 | 29 | $9,180 | $586.28 | 6.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 11 | 31 | $1,054 | $342.88 | 32.5% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 27 | 44 | $264.00 | $21.40 | 8.1% |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2022 | 13 | 2,410 | $156,650 | $82,370 | 52.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 23 | 9,800 | $94,080 | $47,288 | 50.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 23 | 48 | $15,600 | $5,727 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $10,125 | $5,042 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 30 | $4,500 | $2,817 | 62.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 28 | 44 | $4,700 | $2,123 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 24 | $2,400 | $1,431 | 59.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 12 | 13 | $2,860 | $1,377 | 48.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,815 | $785.66 | 43.3% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2022 | 15 | 48 | $2,544 | $778.45 | 30.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 30 | $1,200 | $313.21 | 26.1% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 22 | 37 | $222.00 | $19.19 | 8.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 33 | 15,900 | $147,180 | $73,929 | 50.2% |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2021 | 14 | 1,790 | $116,350 | $66,068 | 56.8% |
About Dr. Nicolas Saikali, MD
Dr. Nicolas Saikali, MD is a Neurology healthcare provider based in Amherst, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2009. The National Provider Identifier (NPI) number assigned to this provider is 1821228511.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicolas Saikali, MD has received a total of $1.7M in payments from pharmaceutical and medical device companies, with $192,491 received in 2024. These payments were reported across 3,985 transactions from 89 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.2M).
As a Medicare-enrolled provider, Saikali has provided services to 983 Medicare beneficiaries, totaling 60,344 services with total Medicare billing of $544,550. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Amherst, NY
- Active Since 07/16/2009
- Last Updated 02/09/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1821228511
Products in Payments
- UBRELVY (Drug) $354,847
- Aimovig (Biological) $239,859
- BOTOX (Biological) $181,562
- QULIPTA (Drug) $170,980
- NURTEC ODT (Drug) $167,747
- VYEPTI (Biological) $97,313
- AJOVY (Biological) $55,923
- Trudhesa (Drug) $43,708
- AJOVY (Drug) $41,384
- Cambia (Drug) $37,459
- BOTOX (Drug) $29,575
- NUEDEXTA (Drug) $24,896
- TROKENDI XR (Drug) $14,811
- Zembrace (Drug) $14,511
- TEV-48125 (Biological) $12,857
- ONZETRA Xsail (Drug) $12,149
- TREXIMET (Drug) $10,251
- EMGALITY (Drug) $9,516
- ZEMBRACE SYMTOUCH (Drug) $8,782
- BOTOX - MIGRAINE (Drug) $5,700
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Amherst
Dr. Jennifer Mcvige, M.d, M.D
Neurology — Payments: $1.0M
Neurology $1.0M
Bennett Myers, M.d, M.D
Neurology — Payments: $538,477
Neurology $538,477
Laszlo Mechtler, Md, MD
Neurology — Payments: $430,778
Neurology $430,778
Dr. Wisam Elmalik, M.d, M.D
Neurology — Payments: $321,171
Neurology $321,171
Dr. Bela Ajtai, Md, Phd, MD, PHD
Neurology — Payments: $135,293
Neurology $135,293
Tomas Holmlund, M.d, M.D
Neurology — Payments: $75,151
Neurology $75,151